N-(3-(5-(2-cyclopropylpyrimidin-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2-fluorophenyl)-1-phenylmethanesulfonamide

ID: ALA4857316

PubChem CID: 156635829

Max Phase: Preclinical

Molecular Formula: C28H22FN5O3S

Molecular Weight: 527.58

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1cccc(NS(=O)(=O)Cc2ccccc2)c1F)c1c[nH]c2ncc(-c3cnc(C4CC4)nc3)cc12

Standard InChI:  InChI=1S/C28H22FN5O3S/c29-25-21(7-4-8-24(25)34-38(36,37)16-17-5-2-1-3-6-17)26(35)23-15-33-28-22(23)11-19(12-32-28)20-13-30-27(31-14-20)18-9-10-18/h1-8,11-15,18,34H,9-10,16H2,(H,32,33)

Standard InChI Key:  AFFJTSUEUAVTPG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   22.5033  -11.3038    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.5075  -12.1287    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.2198  -11.7126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5230  -12.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5217  -13.3143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2366  -13.7272    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2348  -12.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9501  -12.4834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9550  -13.3098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7424  -13.5605    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.2243  -12.8891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7346  -12.2234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8084  -12.0746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8117  -11.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3854  -12.0785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0997  -12.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9849  -11.4374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7909  -11.2612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4293  -10.8276    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.3430  -11.8712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1483  -11.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3992  -10.9086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8388  -10.2975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0357  -10.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7035  -12.3055    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0648  -12.7398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3812  -11.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0973  -10.8323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0912  -12.6568    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.8131  -13.5258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6622  -10.8511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2444  -10.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8372  -10.8573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0068  -13.7007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7551  -14.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3097  -15.0972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1160  -14.9223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3676  -14.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
  4 13  1  0
 13 14  2  0
 14 28  1  0
 27 15  1  0
 15 16  2  0
 16 13  1  0
 12 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 18  1  0
 21 25  1  0
 25  2  1  0
  2 26  1  0
 27 28  2  0
 20 29  1  0
 26 30  1  0
 32 31  1  0
 33 32  1  0
 31 33  1  0
 27 31  1  0
 30 34  1  0
 30 38  2  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4857316

    ---

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP4K5 Tchem Mitogen-activated protein kinase kinase kinase kinase 5 (1523 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K7 Tchem Dual specificity mitogen-activated protein kinase kinase 7 (1145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase 1 (5038 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP3K20 Tchem Mixed lineage kinase 7 (1473 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Map2k4 Dual specificity mitogen-activated protein kinase kinase 4 (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.58Molecular Weight (Monoisotopic): 527.1427AlogP: 5.21#Rotatable Bonds: 8
Polar Surface Area: 117.70Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.57CX Basic pKa: 2.29CX LogP: 4.03CX LogD: 4.01
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.27Np Likeness Score: -1.14

References

1. Klövekorn P, Pfaffenrot B, Juchum M, Selig R, Albrecht W, Zender L, Laufer SA..  (2021)  From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4).,  210  [PMID:33199152] [10.1016/j.ejmech.2020.112963]

Source